BC-DXI-843

BC-DXI-843 is inhibitor of AIMP2-DX2, and is potential for development of novel therapeutics targeting AIMP2-DX2 in lung cancer.

2421117-98-6

≥ 2 years

>98% (HPLC)

546.66

C28H26N4O4S2

Research use only, not for human use.

AIMP2-DX2

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

38308116 3x 1.0 µg

Ask

BML-D108-0100 100 mg

Ask

A21440-1 1 mg

Ask

MBS1472693-01 0.02 mg (E-Coli)

Ask

MBS1472693-02 0.1 mg (E-Coli)

Ask

MBS1472693-03 0.02 mg (Yeast)

Ask